Dividend compounder review

CREO

Creo Medical Group PLC · LSE · GB

Healthcare · Medical Devices

Chart Factor Intelligence Back to Screener
Score28.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 7.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 13.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 5.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£5.3M
Free Cash Flow£-20.0M
FCF Covers DividendUnknown
Debt / Equity8.20
P/E1,260.3
Revenue Growth 5Y-39.6%
Net Margin0.0%
ROE-76.5%
Price vs Trend5.2%
3Y Return-60.6%
5Y Return-93.2%
CurrencyGBP
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Debt to equity is elevated at 8.20.
Dividend diary

Activity record

CREO dividend review warning Warning · Warning

Debt to equity is elevated at 8.20.